1. Home
  2. KBH vs TMDX Comparison

KBH vs TMDX Comparison

Compare KBH & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KB Home

KBH

KB Home

HOLD

Current Price

$42.58

Market Cap

2.6B

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$71.62

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KBH
TMDX
Founded
1957
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.6B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
KBH
TMDX
Price
$42.58
$71.62
Analyst Decision
Hold
Buy
Analyst Count
17
13
Target Price
$52.14
★ $98.73
AVG Volume (30 Days)
★ 1.4M
704.4K
Earning Date
09-22-2026
11-02-2026
Dividend Yield
★ 2.31%
N/A
EPS Growth
N/A
★ 382.18
EPS
★ 2.00
0.61
Revenue
★ $4,547,002,000.00
$605,494,000.00
Revenue This Year
N/A
$22.57
Revenue Next Year
$2.20
$17.85
P/E Ratio
★ $21.65
$115.67
Revenue Growth
N/A
★ 37.13
52 Week Low
$40.92
$60.11
52 Week High
$67.57
$156.00

Technical Indicators

Market Signals
Indicator
KBH
TMDX
Relative Strength Index (RSI) 34.09 34.83
Support Level N/A $66.64
Resistance Level $58.83 $79.60
Average True Range (ATR) 1.25 3.68
MACD 0.06 -0.92
Stochastic Oscillator 26.33 15.25

Price Performance

Historical Comparison
KBH
TMDX

About KBH KB Home

KB Home is an American construction company that focuses on residential construction in the United States. The company builds single-family homes and communities across different geographical segments which include the West Coast which also derives the majority of the revenue, Southwest, Central, and Southeast. The company operates in several markets and focuses on first-time and move-up homebuyers. It also invests in land acquisition and development to support future building activities and is also engaged in financial services operations which includes providing mortgage banking services through its joint venture with a third party.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: